Trial Profile

Phase I/II, Randomized, Double-Blind, Placebo-Controlled, Staged Dosage Escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 3-Dose Series of Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine [BRV-TV] Administered to Healthy Indian Infants Concurrently With Other Standard EPI Vaccines.

Status: Withdrawn prior to enrolment

Phase of Trial: Phase I/II

Latest Information Update: 30 May 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

02 Feb 2010 Status changed from not yet recruiting to withdrawn prior to recruitment, as per ClinicalTrials.gov record.
26 Jun 2009 Planned initiation date changed from 1 Mar 2009 to 1 Sep 2009 as reported by ClinicalTrials.gov.
26 Jun 2009 Planned end date changed from 1 Apr 2010 to 1 Sep 2010 as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com